2021 – Page 2

Our Solution
- Physicians
- Patients
About Artrya
Investor Relations
Contact Us

Request a demonstration

Financial Report for period ended 30 June 2020

Financial Report for period ended 30 June 2021

Appendix 1A & Information Form and Checklist

Previous 1 2 3 Next

Precise diagnosis. Personalized treatment.
Preventative care.

Choose Artrya as your trusted clinical partner.

Contact us today

Coronary artery disease.

We see you.

Sign up to our newsletter

Request a Demo
Contact Us

About Artrya
Investor Relations

Location

1257 Hay Street, West Perth, 6005

X

Salix Coronary Anatomy is listed on the Australian Register of Therapeutic Goods, ID 347719. Salix Coronary Anatomy USA product (K243038) is cleared in the USA.
For the availability of Salix in the EU, UK, US or other jurisdictions, please contact us.

Financial Report for period ended 30 June 2020

Prospectus

Securities Trading Policy

Financial Report for period ended 30 June 2021

Supplementary Prospectus

Incentive Awards Plan 2021

Distribution Schedule

Pre-Quotation Disclosure

Constitution

Appendix 1A & Information Form and Checklist

Sign up to our newsletter